[1]
Skalij , P., Tokajuk , P., Jelski , S. and Wojtukiewicz , M.Z. 2020. Long-term disease control during TAS-102 therapy in the VI line treatment in a 73-year-old mCRC patient. A case report. OncoReview. 10, 1(37) (Mar. 2020), 15-17. DOI:https://doi.org/10.24292/01.OR.120260320.